Covid-19 and Parkinsonism

Herausgegeben:Chaudhuri, K Ray; Rodriguez-Violante, Mayela; Antonini, Angelo; Boura, Iro

• Gebundenes Buch

Produktbeschreibung

Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson's Disease: acute settings and hospital, Covid-19 and Parkinson's Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson's Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson's Disease patients and Covid-19.

Additional sections cover Covid-19 and Parkinson's Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson's Disease patients during the Covid-19 pandemic, Parkinson's Disease and Covid-19: Impact of ethnicity and palliative care, and more.

Produktdetails

• International Review of Neurobiology Volume 165
• Verlag: Academic Press / Elsevier Science & Technology
• Artikelnr. des Verlages: S0074-7742(22)X0005-6
• Englisch
• Abmessung: 18mm x 152mm x 229mm
• Gewicht: 630g
• ISBN-13: 9780323991735
• Artikelnr.: 66014434

Autorenporträt

Attending neurologist at the National Institute of Neurology and Neurosurgery in Mexico City. Responsible of the Clinical Neurodegenerative Research Unit. Movement disorders training at the Hospital Clinic de Barcelona. Master in Sciences granted by the UNAM. Member of the National Research System (SNI level 3). Member of the National Academy of Medicine. Principal Professor of the Parkinson's disease and Movement Disorders high specialty course recognized by the Health's Ministry and the UNAM

Inhaltsangabe

1. Parkinsonism associated with viral infection Irina Ivan, Laura Irincu, ?tefania Diaconu, Cristian Falup-Pecurariu 2. Covid-19, nervous system pathology, and Parkinson's disease: bench to bedside Aron Emmi, Iro Boura, Vanessa Raeder, Donna Mathew, David Sulzer, James E. Goldman, Valentina Leta 3. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital Conor Fearon, Alfonso Fasano 4. Covid-19 and Parkinson's disease: acute clinical implications, long-COVID and post-Covid-19 parkinsonism Valentina Leta, Iro Boura, Daniel J. van Wamelen, Mayela Rodríguez-Violante, Angelo Antonini, K. Ray Chaudhuri 5. Smell deficits in Covid-19 and possible links with Parkinson's disease Aron Emmi, Michele Sandre, Andrea Porzionato, Angelo Antonini 6. Spotlight on non-motor symptoms and Covid-19 Silvia Rota, Iro Boura, Yi-Min Wan, Claudia Lazcano-Ocampo, Mayela Rodríguez-Violante, Angelo Antonini, K. Ray Chaudhuri 7. Treatment paradigms in Parkinson's disease patients and Covid-19 Iro Boura, Lucia Batzu, Espen Dietrichs, K. Ray Chaudhuri 8. Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies Anna Roszmann, Aleksandra M. Podlewska, Yue Hui Lau, Iro Boura, Annette Hand 9. Social Isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease Bradley McDaniels, Indu Subramanian 10. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care Katarina Rukavina, Victor McConvey, K. Ray Chaudhuri, Janis Miyasaki 11. Covid-19 : The Cynosure of Rise of Parkinson's Disease Prashanth Lingappa Kukkle 12. Parkinson's disease and Covid-19: The Effect and Use of Telemedicine Aleksandra M. Podlewska, Daniel J. van Wamelen 13. Impact of Covid-19 on research and training in Parkinson's disease Yi-Min Wan, Daniel J. van Wamelen, Yue Hui Lau, Silvia Rota, Eng-King Tan